Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for
Low Risk Myelodysplastic Syndromes
Location: Durham NC, Columbus OH, Cleveland OH, New York NY,
Sponsor: Rigel Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05308264

Phase1, Phase2, Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Durham NC, New York NY, Nashville TN, Providence RI,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase1, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Durham NC, Fayetteville NC, Greensboro NC, Richmond VA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Durham NC, Fairfax VA, Philadelphia PA, Nashville TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase1, Recruiting

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for
Prostate Cancer,
Location: Durham NC, Myrtle Beach SC, Charlottesville VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT04729114

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Durham NC, Huntersville NC, Fairfax VA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase1, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Durham NC, Washington DC, Baltimore MD, Boston MA,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase1, Recruiting

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Durham NC, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 3 - 39

Code: NCT05096481

Phase2, Recruiting

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

for
Relapsed/Refractory Acute Myeloid Leukemia (AML),
Location: Durham NC, Atlanta GA, New York NY, Birmingham AL,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05143996

Phase1, Recruiting

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

for
Solid Tumors
Location: Durham NC, Atlanta GA, Toronto, Boston MA, St Louis MO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05203172

Recruiting

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation

Sex: All

Age: 65+

Code: NCT02802267

Phase2, Recruiting

Optimizing Surgical Decisions in Young Adults With Breast Cancer

for
Breast Cancer Stage 0, Breast Cancer Stage I,
Location: Durham NC, New York NY, New Haven CT, Boston MA
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 44

Code: NCT06275126

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Durham NC, Charlotte NC, Washington D.C. DC,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase3, Recruiting

Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

for
Liver Cancer
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT04933435

Recruiting

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

for
Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
Location: Durham NC, Richmond VA, Hershey PA, Atlanta GA,
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT03567889

Phase3, Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for
Prostate Cancer
Location: Durham NC, Chapel Hill NC, Charlottesville VA,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 21+

Code: NCT03151629

Recruiting

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

for
Brain Tumor, Primary, Brain Metastases, Adult
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT05480644

Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Durham NC, Chesapeake VA, Fairfax VA, Philadelphia PA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase2, Recruiting

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

for
Ovarian Cancer, Advanced Ovarian Carcinoma,
Location: Durham NC, Boston MA, Aurora CO, Boulder CO
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT06710548

Recruiting

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.

Sex: All

Age: 18+

Code: NCT05338073

Recruiting